×
It looks like you're using an obsolete version of internet explorer. Internet explorer is no longer supported by Microsoft since the end of 2015. We invite you to use a newer browser such as Firefox, Google Chrome or Microsoft Edge.
My Player placeholder

Become an Oncostream member and receive full access to its content!

You must be an Oncostream member to access videos without any restrictions. Register for free in one minute and access all services provided by Oncostream.You will also be able to log into Oncostream from your Facebook or twitter account by clicking on login on the top-right corner of Oncostream website.

Registration Login


Worldwide schedules comment Share

Contexte :

 

Le congrès américain a apporté son lot de données nouvelles sur la prise en charge du cancer de l’ovaire en première ligne.

 

Quels impacts concrets pour la pratique clinique ? Quels ajustements envisager dès maintenant ?

 

Deux experts vous proposent un décryptage ciblé des évolutions thérapeutiques à connaître, en seulement 45 minutes.

 

Intervenants :

 

Dr Alexandra Léary

Pr Fabrice Lécuru

 

Programme :

 

- Les nouveautés médicales, Alexandra Léary

- L'étude TRUST, Fabrice Lécuru

Débat/discussion & Réponses aux questions

 

Shooting date : 2025-07-01
Last update : 2025-07-09
Alexandra Léary
Villejuif, France
Oncology
Fabrice Lécuru
Paris, France
Gynecology

Suggestions

Monday, April 28th 2025 from 06:30pm to 07:30pm (GMT+2)
Honolulu : Monday, April 28th 2025 from 06:30am to 07:30am (GMT+2)
San Francisco : Monday, April 28th 2025 from 09:30am to 10:30am (GMT+2)
New York : Monday, April 28th 2025 from 12:30pm to 01:30pm (GMT+2)
Buenos Aires : Monday, April 28th 2025 from 01:30pm to 02:30pm (GMT+2)
Reykjavik : Monday, April 28th 2025 from 04:30pm to 05:30pm (GMT+2)
London / Dublin : Monday, April 28th 2025 from 05:30pm to 06:30pm (GMT+2)
Paris / Berlin : Monday, April 28th 2025 from 06:30pm to 07:30pm (GMT+2)
Istanbul : Monday, April 28th 2025 from 07:30pm to 08:30pm (GMT+2)
Moscou / Dubaï : Monday, April 28th 2025 from 08:30pm to 09:30pm (GMT+2)
Bangkok : Monday, April 28th 2025 from 11:30pm to 12:30am (GMT+2)
Shanghai : Tuesday, April 29th 2025 from 12:30am to 01:30am (GMT+2)
Tokyo : Tuesday, April 29th 2025 from 01:30am to 02:30am (GMT+2)
Sydney : Tuesday, April 29th 2025 from 03:30am to 04:30am (GMT+2)
Wellington : Tuesday, April 29th 2025 from 05:30am to 06:30am (GMT+2)

PARPi dans le cancer de l'ovaire en 1L

Données actuelles et perspectives pour la combinaison avec l’IO

Share
Wednesday, May 18th 2022 from 06:30pm to 08pm (GMT+2)
Honolulu : Wednesday, May 18th 2022 from 06:30am to 08am (GMT+2)
San Francisco : Wednesday, May 18th 2022 from 09:30am to 11am (GMT+2)
New York : Wednesday, May 18th 2022 from 12:30pm to 02pm (GMT+2)
Buenos Aires : Wednesday, May 18th 2022 from 01:30pm to 03pm (GMT+2)
Reykjavik : Wednesday, May 18th 2022 from 04:30pm to 06pm (GMT+2)
London / Dublin : Wednesday, May 18th 2022 from 05:30pm to 07pm (GMT+2)
Paris / Berlin : Wednesday, May 18th 2022 from 06:30pm to 08pm (GMT+2)
Istanbul : Wednesday, May 18th 2022 from 07:30pm to 09pm (GMT+2)
Moscou / Dubaï : Wednesday, May 18th 2022 from 08:30pm to 10pm (GMT+2)
Bangkok : Wednesday, May 18th 2022 from 11:30pm to 01am (GMT+2)
Shanghai : Thursday, May 19th 2022 from 12:30am to 02am (GMT+2)
Tokyo : Thursday, May 19th 2022 from 01:30am to 03am (GMT+2)
Sydney : Thursday, May 19th 2022 from 03:30am to 05am (GMT+2)
Wellington : Thursday, May 19th 2022 from 05:30am to 07am (GMT+2)

Importance de la chimio-sensibilité dans la prise en charge des cancers de l’ovaire

Share
Tuesday, September 19th 2023 from 06pm to 07:30pm (GMT+2)
Honolulu : Tuesday, September 19th 2023 from 06am to 07:30am (GMT+2)
San Francisco : Tuesday, September 19th 2023 from 09am to 10:30am (GMT+2)
New York : Tuesday, September 19th 2023 from 12pm to 01:30pm (GMT+2)
Buenos Aires : Tuesday, September 19th 2023 from 01pm to 02:30pm (GMT+2)
Reykjavik : Tuesday, September 19th 2023 from 04pm to 05:30pm (GMT+2)
London / Dublin : Tuesday, September 19th 2023 from 05pm to 06:30pm (GMT+2)
Paris / Berlin : Tuesday, September 19th 2023 from 06pm to 07:30pm (GMT+2)
Istanbul : Tuesday, September 19th 2023 from 07pm to 08:30pm (GMT+2)
Moscou / Dubaï : Tuesday, September 19th 2023 from 08pm to 09:30pm (GMT+2)
Bangkok : Tuesday, September 19th 2023 from 11pm to 12:30am (GMT+2)
Shanghai : Wednesday, September 20th 2023 from 12am to 01:30am (GMT+2)
Tokyo : Wednesday, September 20th 2023 from 01am to 02:30am (GMT+2)
Sydney : Wednesday, September 20th 2023 from 03am to 04:30am (GMT+2)
Wellington : Wednesday, September 20th 2023 from 05am to 06:30am (GMT+2)

Prise en charge des carcinomes séreux de bas grade en 2023

Share
Tuesday, November 21st 2023 from 06pm to 07:30pm (GMT+1)
Honolulu : Tuesday, November 21st 2023 from 06am to 07:30am (GMT+1)
San Francisco : Tuesday, November 21st 2023 from 08am to 09:30am (GMT+1)
New York : Tuesday, November 21st 2023 from 11am to 12:30pm (GMT+1)
Buenos Aires : Tuesday, November 21st 2023 from 01pm to 02:30pm (GMT+1)
London / Dublin : Tuesday, November 21st 2023 from 04pm to 05:30pm (GMT+1)
Paris / Berlin : Tuesday, November 21st 2023 from 05pm to 06:30pm (GMT+1)
Istanbul : Tuesday, November 21st 2023 from 06pm to 07:30pm (GMT+1)
Moscou / Dubaï : Tuesday, November 21st 2023 from 08pm to 09:30pm (GMT+1)
Bangkok : Tuesday, November 21st 2023 from 11pm to 12:30am (GMT+1)
Shanghai : Wednesday, November 22nd 2023 from 12am to 01:30am (GMT+1)
Tokyo : Wednesday, November 22nd 2023 from 01am to 02:30am (GMT+1)
Sydney : Wednesday, November 22nd 2023 from 02am to 03:30am (GMT+1)
Wellington : Wednesday, November 22nd 2023 from 04am to 05:30am (GMT+1)

Cancer de l'ovaire : comment évaluer aujourd'hui la recombinaison homologue ?

Share
Scroll Up